Table 3. A summary for sensitivity of GPC-3 in various liver nodules.
| FNH | HCA | Cirrhosis | LRN | NTL | LGDN | HGDN | HCC | |
|---|---|---|---|---|---|---|---|---|
| Baumhoer 2008@[26] | 11/95 | 0/8 | 0/16 | 0/7 | 6/31 | 140/220 | ||
| Di Tommaso 2009[34] | 1/13 | 0/21 | 4/50 | 65/92 | ||||
| Yamauchi 2005[35] | 1/3 | 0/7 | 0/43 | 0/25 | 2/8 | 6/8 | 47/56 | |
| Wang 2008[20] | 0/30 | 0/48 | 0/32 | 84/111 | ||||
| Wang 2010 #[30] | 0/9 | 0/5 | 0/7 | 45/54 | ||||
| Libbrecht 2006[23] | 0/11 | 0/14 | 2/29 | 36/47 | ||||
| Cappuro 2003*[21] | 0/4 | 0/7 | 0/22 | 0/7 | 1/5 | 20/26 | ||
| Wang 2006 @*[27] | 0/14 | 16/94 | 0/42 | 2/23 | 2/9 | 50/74 | ||
| Shafizadeh 2008[18] | 0/8 | 4/35 | 0/10 | 3/7 | 58/79 | |||
| Coston 2008[22] | 0/16 | 0/19 | 4/78 | 95/107 | ||||
| Total | 1/73 | 0/103 | 35/372 | 1/105 | 0/48 | 4/80 | 24/139 | 640/866 |
| (positivity rates in pooled series) | (1.4%) | (0%) | (10.4%) | (1.0%) | (0%) | (5.0%) | (17.3%) | (73.9%) |
@, tissue microarray; #, biopsy cases; *HCC including fibrolamellar HCC but excluding combined type; NTL, normal liver tissue.